Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification-Reference-Cited by-同舟云学术

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification

Published:2019-06-19 Issue:3 Volume:124 Page:532-544
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ward Douglas G.¹^ORCID,Gordon Naheema S.¹,Boucher Rebecca H.¹,Pirrie Sarah J.¹,Baxter Laura²,Ott Sascha²,Silcock Lee³,Whalley Celina M.¹,Stockton Joanne D.¹,Beggs Andrew D.¹,Griffiths Mike⁴,Abbotts Ben¹,Ijakipour Hanieh¹,Latheef Fathimath N.¹,Robinson Robert A.¹,White Andrew J.¹,James Nicholas D.¹^ORCID,Zeegers Maurice P.⁵,Cheng K. K.⁶,Bryan Richard T.¹^ORCID

Affiliation:

1. Institute of Cancer and Genomic Sciences; University of Birmingham; Birmingham UK

2. Department of Computer Science; University of Warwick; Coventry UK

3. Nonacus Limted; Birmingham Research Park; Birmingham UK

4. West Midlands Regional Genetics Laboratory; Birmingham Women's and Children's NHS Foundation Trust; Birmingham UK

5. NUTRIM School for Nutrition and Translational Research in Metabolism and CAPHRI Care and Public Health Research Institute; Maastricht University; Maastricht The Netherlands

6. Institute of Applied Health Research; University of Birmingham; Birmingham UK

Funder

Birmingham and The Black Country and West Midlands

North and South Comprehensive Local Research Networks

Cancer Research UK

University of Birmingham

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14808/fullpdf